Extendicare Inc. (TSE:EXE) Shareholders to Collect $0.04 Monthly Dividend

Key Points

• Extendicare declared a monthly dividend of C$0.0441 per share, equivalent to C$0.53 annually and a 2.0% yield. The ex-dividend date was October 30, with payment scheduled for November 16 to shareholders of record.
• The company reported quarterly earnings of C$0.38 per share on revenue of C$611.04 million, with a 6.13% net margin and 36.33% return on equity.
• Analysts maintain a favorable outlook, with all seven tracked analysts rating the stock Buy and a consensus price target of C$37.00, above its reported C$26.90 opening price.

Extendicare Inc. (TSE:EXE - Get Free Report) declared a monthly dividend on Friday, October 30th. Shareholders of record on Monday, November 16th will be given a dividend of $0.0441 per share on Monday, November 16th. This represents a $0.53 annualized dividend and a dividend yield of 2.0%. The ex-dividend date of this dividend is Friday, October 30th.

Extendicare Price Performance

Shares of Extendicare stock opened at C$26.90 on Wednesday. The firm has a market cap of C$2.56 billion, a PE ratio of 20.60 and a beta of 1.39. The stock has a 50 day moving average of C$29.57 and a 200 day moving average of C$29.82. The company has a current ratio of 0.75, a quick ratio of 0.98 and a debt-to-equity ratio of 159.54. Extendicare has a 12 month low of C$15.64 and a 12 month high of C$39.14.

Extendicare (TSE:EXE - Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The company reported C$0.38 earnings per share for the quarter. The company had revenue of C$611.04 million for the quarter. Extendicare had a net margin of 6.13% and a return on equity of 36.33%. On average, research analysts expect that Extendicare will post 0.61 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on EXE. National Bank Financial decreased their target price on Extendicare from C$45.00 to C$40.00 and set an "outperform" rating for the company in a research report on Wednesday, October 21st. Royal Bank Of Canada raised their price target on shares of Extendicare from C$38.00 to C$39.00 and gave the stock an "outperform" rating in a research note on Friday, August 14th. Desjardins lowered their price objective on shares of Extendicare from C$40.00 to C$39.00 and set a "buy" rating for the company in a research report on Monday, August 10th. Finally, Canaccord Genuity Group boosted their price objective on shares of Extendicare from C$37.00 to C$44.00 and gave the company a "buy" rating in a research report on Monday, August 10th. Seven investment analysts have rated the stock with a Buy rating. According to data from MarketBeat.com, Extendicare has an average rating of "Buy" and a consensus target price of C$37.00.

About Extendicare

Extendicare is a leading provider of care and services for seniors across Canada, operating under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Network brands. We are committed to delivering quality care to meet the needs of the growing seniors' population, inspired by our mission to provide people with the care they need, wherever they call home. We deliver more than 27 million hours of home health care services annually, operate a network of 97 long-term care homes (58 owned, 39 under management contracts), and provide group purchasing services to third parties representing approximately 161,700 beds across Canada.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.